<div id="readability-page-1">DexCom, Inc. (NASDAQ:DXCM) is one of the stocks on Jim Cramer’s radar recently. A caller asked if they should buy, sell, or hold the stock during the lightning round. In response, Cramer said: “You know, it’s too rich a stock, and I do think the GLP-1s are going to have such a dramatic effect on […]</div>

德康醫療

<p>德康醫療（DexCom, Inc.）（NASDAQ:DXCM）是吉姆·克萊默最近關注的股票之一。在快速問答環節中，一位來電者詢問是否應該買入、賣出或持有該股票。對此，克萊默表示：“你知道，這是一隻價格過高的股票，我確實認為 GLP-1 類藥物將會對……產生如此顯著的影響。”</p>

Jim Cramer 對德康醫療的評價：“這隻股票定價過高”